Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

03 sept. 2014 05h54 HE | Source: Allarity Therapeutics, Inc.

MPI - VEDTÆGTER

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} VEDTÆGTER Medical Prognosis Institute A/S...
02 sept. 2014 10h28 HE | Source: Allarity Therapeutics, Inc.

Medical Prognosis Institute A/S - Passing of Extraordinary General Meeting

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Hoersholm; September 2, 2014 - On Tuesday 2...
02 sept. 2014 10h28 HE | Source: Allarity Therapeutics, Inc.

Medical Prognosis Institute A/S - Forløb af ekstraordinær generalforsamling

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Hørsholm; 2. september 2014 - Tirsdag den 2....
15 août 2014 08h00 HE | Source: Allarity Therapeutics, Inc.

MPI - Notice of Extraordinary General Meeting in Medical Prognosis Institute A/S

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Hoersholm; August 15, 2014 - The board of Medical...
15 août 2014 08h00 HE | Source: Allarity Therapeutics, Inc.

MPI - Indkaldelse til ekstraordinær generalforsamling i Medical Prognosis Institute A/S

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Hørsholm; 15.august 2014 - Bestyrelsen for...
12 août 2014 11h43 HE | Source: Allarity Therapeutics, Inc.

Medical Prognosis Institute A/S - Interim Report First Half 2014

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Hoersholm; April 12th 2014 - Medical Prognosis...
07 août 2014 07h42 HE | Source: Allarity Therapeutics, Inc.

MPI advances the date for publication of its scheduled H1 report for 2014

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Hoersholm; August 07, 2014 - Medical Prognosis...
11 juil. 2014 02h18 HE | Source: Allarity Therapeutics, Inc.

MPI's Lung Prognostic Chip study expanded with new gene test - publication of data consequently postponed to H1 2015

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Hoersholm; July 11 2014 - Medical Prognosis...
27 mai 2014 09h59 HE | Source: Allarity Therapeutics, Inc.

MPI and LiPlasome present the phase 1 study with LiPlaCis at the ASCO congress Monday 2 in Chicago at 8am local time

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Hoersholm; May 27 2014 - Medical Prognosis...
23 mai 2014 09h00 HE | Source: Allarity Therapeutics, Inc.

MPI increases its capital by 67,774 shares as a result of the capital increase adopted on the annual general meeting held on 24 April 2014

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Hoersholm; May 23 2014 - Medical Prognosis...

Page précédente